- GlaxoSmithKline PLC stock price today and history
GlaxoSmithKline PLC (GSK) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
GlaxoSmithKline PLC stock price
GlaxoSmithKline PLC latest news:
UK fraud office expects decision on GSK, Rolls-Royce cases next year
LONDON, Aug 10 (Reuters) - The UK Serious Fraud Office (SFO)
said on Thursday it expects to decide next year whether it will
file criminal charges in bribery investigations related to drugs
giant GlaxoSmithKline and aero engine company
United Therapeutics Corp. stock surges 9% on report of possible bids for company
United Therapeutics Corp. shares surged 8.7% premarket on Friday after a news report suggested that major pharmaceutical companies were weighing a bid for it. The Evening Standard report said that Gilead Sciences Inc. is considered the frontrunner, while GlaxoSmithKline PLC and Novartis AG are also possible contenders. Glaxo and United Therapeutics declined to comment to the Evening Standard. United Therapeutic, which was founded by Martine Rothblatt, a co-founder of Sirius XM , currently has five products on the market, four of which treat pulmonary arterial hypertension; the fifth is intended for pediatric cancer patients. United Therapeutics shares have dropped 11.5% year-to-date, compared with a 10.4% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
GSK gives up on rare diseases as gene therapy gets two customers
LONDON, July 26 (Reuters) - GlaxoSmithKline is
swimming against the tide by getting out of treatments for rare
diseases at a time when rivals like Sanofi and Shire
see the field as a rich seam for profits.
BRIEF-GSK to sell UK Horlicks business
Glaxosmithkline Plc(GSK): * Announces updates on UK manufacturing network. * Proposals announced today for Worthing and Slough will result in a reduction of approximately 320 permanent jobs over next 4 years. * Between now and 2020, plans to invest more than 140 mln stg at Ware, Hertfordshire, Barnard Castle, Co Durham, Montrose, Scotland sites.
Big pharma turns to AI to speed drug discovery, GSK signs deal
LONDON (Reuters) - The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.
New GSK chief Walmsley eyes MaxiMuscle sale
The new chief executive of GlaxoSmithKline (GSK) is kicking off her tenure with a move to offload the division which owns Maximuscle, a nutritional products brand favoured by elite athletes.
GSK's new pharma head to join in September after AstraZeneca tussle
LONDON (Reuters) - GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca.
Global Brass and Copper HoldingsBRSS
Global Cash Access HoldingsGCA
Global High Income Dollar FundGHI
Global Net LeaseGNL
Global Partners LPGLP
Global Payments Inc.GPN
Global Power Equipment Group IncGLPW
Global Ship LeaseGSL
Global Ship LeaseGSL^B